男性无症状肾下腹主动脉瘤择期治疗最佳直径阈值:蒙特卡洛模拟研究
该蒙特卡洛模拟研究比较了男性初始直径55 mm肾下腹主动脉瘤行EVAR或OSR时,不同风险组延迟或提前手术对生存的影响。降低死亡率的最佳阈值在各风险组一致(EVAR 56–57 mm,OSR 55–57 mm),而最大化累积生命年的阈值随风险变化,尤其高危OSR患者升至64 mm。患者预期寿命是决定最佳时机的主导因素,支持个体化、基于风险的AAA管理。
要点
- 以降低死亡率为目标时,EVAR和OSR的最佳阈值在各风险组均稳定在55–57 mm左右。
- 以最大化累积生命年为目标时,高危患者行OSR的最佳阈值升至64 mm,低危为57 mm。
- 高危OSR患者在55 mm而非64 mm手术,损失2.1%累积生命年(95%CI 1.7%获益至5.8%损失)。
核心结论
- 最佳择期AAA修复阈值取决于优先结局:降低死亡率的阈值跨风险组稳定,而最大化累积生命年的阈值变异大,尤其高危患者行OSR时。
- 患者预期寿命是决定最佳手术时机的主导因素,支持基于风险的个体化AAA管理。
研究设计与样本
- 蒙特卡洛模拟研究,比较男性初始肾下AAA直径55 mm行择期EVAR与OSR。
- 按年龄、肾功能和COPD分为四个风险组,每组EVAR和OSR各模拟10 000例患者。
- 模型纳入动脉瘤生长、破裂风险及基线和围手术期死亡率,评估55 mm至75 mm的治疗阈值。
主要发现
- 降低死亡率的最佳阈值在各风险组一致:EVAR为56–57 mm,OSR为55–57 mm。
- 最大化累积生命年的EVAR阈值稳定在55–57 mm。
- 最大化累积生命年的OSR阈值随风险增加,从低危57 mm升至高危64 mm。
- 高危OSR患者在55 mm而非64 mm手术,损失2.1%累积生命年(95%CI 1.7%获益至5.8%损失)。
- 敏感性分析显示院外死亡、围手术期死亡、破裂率和生长率变异对死亡率最佳阈值影响极小,而累积生命年最佳阈值变异较大,尤其OSR。
关键数值与推荐
- 降低死亡率的最佳阈值:EVAR 56–57 mm,OSR 55–57 mm(各风险组一致)。
- 最大化累积生命年的EVAR阈值:55–57 mm。
- 最大化累积生命年的OSR阈值:低危57 mm至高危64 mm。
临床怎么用
- 临床决策应明确优先目标(降低死亡率或最大化累积生命年),并据此选择个体化AAA修复阈值。
- 对高危患者行OSR时,可考虑将手术阈值提高至约64 mm以最大化累积生命年,而非仅依据死亡率阈值。
- 患者预期寿命是决定最佳手术时机的关键因素,应纳入共享决策。
局限性
- 研究为蒙特卡洛模拟,结果依赖模型假设和输入参数,需临床数据验证。
- 仅纳入男性、初始直径55 mm的肾下AAA,结论外推至女性或其他直径患者受限。
- 未报告模型参数的具体来源和不确定性范围。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: The optimal timing for elective infrarenal abdominal aortic aneurysm (AAA) repair in men remains uncertain, particularly among patients with varying comorbidities. A microsimulation model was used to evaluate how patient risk and aneurysm behaviour influence survival outcomes when repair is delayed or expedited. METHODS: This was a Monte Carlo simulation study. A ten year microsimulation compared elective endovascular aortic repair (EVAR) and open surgical repair (OSR) in men with an initial infrarenal AAA diameter of 55 mm. Eight scenarios were simulated: four risk groups by age, renal function, and chronic obstructive pulmonary disease, each for EVAR and OSR, with 10 000 patients per scenario. The model incorporated aneurysm growth, rupture risk, and baseline and peri-operative mortality, and evaluated treatment thresholds from 55 mm to 75 mm. The primary outcome was the diameter threshold minimising all cause mortality; the secondary outcome was maximising cumulative life years (CLYs). RESULTS: Optimal thresholds for minimising mortality were consistent across risk groups, ranging from 56 - 57 mm for EVAR and 55 - 57 mm for OSR. Thresholds maximising CLYs for EVAR remained stable between 55 mm and 57 mm. For OSR, thresholds increased with patient risk, ranging from 57 mm in low risk patients to 64 mm in high risk patients. In high risk patients undergoing OSR, treatment at 55 mm instead of at the CLY optimal threshold of 64 mm resulted in a loss of 2.1% of CLYs (95% confidence interval 1.7% gain to 5.8% loss). Sensitivity analyses demonstrated minimal impact of variation in out of hospital death, peri-operative death, rupture rates, and growth rates on mortality optimal thresholds, while CLY optimal thresholds, particularly for OSR, showed greater variability. CONCLUSION: Optimal elective AAA repair thresholds differ depending on the outcome prioritised. Mortality minimising thresholds were stable across risk groups, whereas CLY optimal thresholds varied substantially, particularly for OSR in high risk patients. Patient life expectancy emerged as the dominant determinant of optimal timing, supporting a more individualised, risk based approach to AAA management.
引用
- Pouncey AL, Resch TA, Zimmermann A, et al. Optimal Elective Treatment Threshold for Men with Asymptomatic Infrarenal Abdominal Aortic Aneurysms: A Monte Carlo Simulation Study. Eur J Vasc Endovasc Surg. 2026. PMID: 42705524. doi:10.1016/j.ejvs.2026.09.003
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。